Age distribution of patients with advanced non-melanoma skin cancer in the United States
Open Access
- 21 April 2013
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 305 (9) , 845-850
Abstract
The epidemiology of non-melanoma skin cancer (NMSC) is not well understood due to exclusion from most US cancer registries. Patients with at least two claims with a NMSC diagnosis (ICD-9-CM 173.xx) at least 60 days apart, or at least one claim for a NMSC-specific treatment from 1/2010 to 12/2010, were identified from a large US commercial insurance claims database and grouped into one of three cohorts: metastatic (MET), locally advanced (LA), or “all other”. MET patients had at least two claims with a metastasis code at least 30 days apart. LA patients had at least two visits to a medical oncologist, one diagnostic imaging service, two radiation therapy services, or one visit to two or more physician specialties. Remaining patients were “all other”. Incidence and prevalence of NMSC were calculated from among the total number of persons continuously enrolled in the plan during the study period and standardized to the 2010 US population. From among 6,610,256 patients, there were 47,451 incident cases of NMSC (MET n = 16, LA n = 387, all other n = 47,048). The age-adjusted incidence rate of 693 per 100,000 persons (2010 population) approximates to 2,139,535 total NMSC cases in the US (0.7 % of population). 671 prevalent cases had advanced disease (MET n = 43, LA n = 628); an age-adjusted rate of 0.6 and 10 per 100,000 US persons equivalent to 1,993 and 29,841 MET and LA cases, respectively. Although NMSCs rarely progress, the number of patients with advanced disease is significant. Further studies to determine proportions of advanced NMSC by subtype are needed.Keywords
This publication has 13 references indexed in Scilit:
- Risk of Mortality, Fatal Infection, and Fatal Malignancy Related to Use of Anti-Tumor Necrosis Factor-α Biologics by Rheumatoid Arthritis PatientsSeminars in Arthritis and Rheumatism, 2012
- A systematic review of worldwide incidence of nonmelanoma skin cancerBritish Journal of Dermatology, 2012
- Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006Archives of Dermatology, 2010
- Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian populationJournal of the American Academy of Dermatology, 2005
- Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer)British Journal of Dermatology, 2003
- Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico.2003
- Epidemiology of Skin Tumors: Data from the Cutaneous Cancer Registry in Trentino, ItalyJournal of Cutaneous Medicine and Surgery, 2003
- Skin cancer is among the most costly of all cancers to treat for the Medicare populationJournal of the American Academy of Dermatology, 2003
- Basal Cell Carcinoma Metastatic to the Parotid: Report of a New Case and Review of the LiteratureEar, Nose & Throat Journal, 2000
- The Epidemiology of Non‐Melanoma Skin Cancer: Who, Why and What Can We Do about ItThe Journal of Dermatology, 1995